buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion
-
Add time:08/30/2019 Source:sciencedirect.com
Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine (cas 136232-82-1) is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD.
We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers
Prev:Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology
Next:Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationPerceived need and availability of psychosocial interventions across buprenorphine (cas 136232-82-1) prescriber specialties09/07/2019
- Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers09/06/2019
- A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings09/05/2019
- Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence09/04/2019
- Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion09/03/2019
- Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program09/02/2019
- Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)09/01/2019
- Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study08/31/2019
- Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology08/29/2019
-
Health and Chemical more >
-
Related Products


